nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ERBB3—gallbladder cancer	0.598	0.69	CbGaD
Gefitinib—EGFR—gallbladder cancer	0.268	0.31	CbGaD
Gefitinib—ORM1—bile—gallbladder cancer	0.00573	0.156	CbGeAlD
Gefitinib—Lapatinib—ERBB4—gallbladder cancer	0.00219	0.21	CrCbGaD
Gefitinib—Lapatinib—ERBB2—gallbladder cancer	0.00161	0.155	CrCbGaD
Gefitinib—ORM1—gall bladder—gallbladder cancer	0.00159	0.0434	CbGeAlD
Gefitinib—Afatinib—ERBB4—gallbladder cancer	0.00155	0.149	CrCbGaD
Gefitinib—ERBB3—epithelium—gallbladder cancer	0.00147	0.04	CbGeAlD
Gefitinib—MKNK2—epithelium—gallbladder cancer	0.0014	0.038	CbGeAlD
Gefitinib—ALB—gall bladder—gallbladder cancer	0.0014	0.038	CbGeAlD
Gefitinib—CSNK1E—pancreas—gallbladder cancer	0.00136	0.0369	CbGeAlD
Gefitinib—ERBB3—pancreas—gallbladder cancer	0.00131	0.0356	CbGeAlD
Gefitinib—MKNK2—pancreas—gallbladder cancer	0.00124	0.0339	CbGeAlD
Gefitinib—IRAK1—pancreas—gallbladder cancer	0.00124	0.0339	CbGeAlD
Gefitinib—SBK1—lymph node—gallbladder cancer	0.0012	0.0326	CbGeAlD
Gefitinib—Afatinib—ERBB2—gallbladder cancer	0.00114	0.11	CrCbGaD
Gefitinib—CHEK2—lymph node—gallbladder cancer	0.00104	0.0284	CbGeAlD
Gefitinib—EGFR—liver—gallbladder cancer	0.000897	0.0244	CbGeAlD
Gefitinib—CSNK1E—liver—gallbladder cancer	0.000863	0.0235	CbGeAlD
Gefitinib—IRAK4—liver—gallbladder cancer	0.000849	0.0231	CbGeAlD
Gefitinib—ERBB3—liver—gallbladder cancer	0.000832	0.0227	CbGeAlD
Gefitinib—MKNK2—liver—gallbladder cancer	0.000791	0.0216	CbGeAlD
Gefitinib—IRAK1—liver—gallbladder cancer	0.000791	0.0216	CbGeAlD
Gefitinib—MKNK1—liver—gallbladder cancer	0.000781	0.0213	CbGeAlD
Gefitinib—Lapatinib—EGFR—gallbladder cancer	0.000763	0.0732	CrCbGaD
Gefitinib—EGFR—lymph node—gallbladder cancer	0.000688	0.0187	CbGeAlD
Gefitinib—Bosutinib—ERBB4—gallbladder cancer	0.000674	0.0647	CrCbGaD
Gefitinib—CSNK1E—lymph node—gallbladder cancer	0.000661	0.018	CbGeAlD
Gefitinib—IRAK4—lymph node—gallbladder cancer	0.000651	0.0177	CbGeAlD
Gefitinib—STK10—liver—gallbladder cancer	0.000644	0.0175	CbGeAlD
Gefitinib—ERBB3—lymph node—gallbladder cancer	0.000638	0.0174	CbGeAlD
Gefitinib—MKNK2—lymph node—gallbladder cancer	0.000607	0.0165	CbGeAlD
Gefitinib—IRAK1—lymph node—gallbladder cancer	0.000607	0.0165	CbGeAlD
Gefitinib—MKNK1—lymph node—gallbladder cancer	0.000599	0.0163	CbGeAlD
Gefitinib—MAP2K5—liver—gallbladder cancer	0.000575	0.0157	CbGeAlD
Gefitinib—Vandetanib—ERBB3—gallbladder cancer	0.000562	0.0539	CrCbGaD
Gefitinib—Afatinib—EGFR—gallbladder cancer	0.000541	0.0519	CrCbGaD
Gefitinib—Bosutinib—ERBB3—gallbladder cancer	0.000525	0.0504	CrCbGaD
Gefitinib—STK10—lymph node—gallbladder cancer	0.000493	0.0134	CbGeAlD
Gefitinib—CYP1A1—epithelium—gallbladder cancer	0.000468	0.0128	CbGeAlD
Gefitinib—ORM1—liver—gallbladder cancer	0.000467	0.0127	CbGeAlD
Gefitinib—MAP2K5—lymph node—gallbladder cancer	0.000441	0.012	CbGeAlD
Gefitinib—ALB—liver—gallbladder cancer	0.000409	0.0111	CbGeAlD
Gefitinib—CYP3A5—pancreas—gallbladder cancer	0.000408	0.0111	CbGeAlD
Gefitinib—Erlotinib—EGFR—gallbladder cancer	0.000382	0.0367	CrCbGaD
Gefitinib—ORM1—lymph node—gallbladder cancer	0.000358	0.00975	CbGeAlD
Gefitinib—CYP2C19—liver—gallbladder cancer	0.000329	0.00898	CbGeAlD
Gefitinib—ALB—lymph node—gallbladder cancer	0.000314	0.00855	CbGeAlD
Gefitinib—ABCG2—liver—gallbladder cancer	0.00028	0.00762	CbGeAlD
Gefitinib—CYP1A1—liver—gallbladder cancer	0.000265	0.00723	CbGeAlD
Gefitinib—CYP3A5—liver—gallbladder cancer	0.00026	0.00707	CbGeAlD
Gefitinib—CYP2C9—liver—gallbladder cancer	0.000255	0.00696	CbGeAlD
Gefitinib—Vandetanib—EGFR—gallbladder cancer	0.000252	0.0241	CrCbGaD
Gefitinib—ABCB1—epithelium—gallbladder cancer	0.000243	0.00663	CbGeAlD
Gefitinib—Bosutinib—EGFR—gallbladder cancer	0.000236	0.0226	CrCbGaD
Gefitinib—ABCB1—pancreas—gallbladder cancer	0.000217	0.0059	CbGeAlD
Gefitinib—ABCG2—lymph node—gallbladder cancer	0.000214	0.00584	CbGeAlD
Gefitinib—CYP1A1—lymph node—gallbladder cancer	0.000204	0.00554	CbGeAlD
Gefitinib—CYP3A4—liver—gallbladder cancer	0.000195	0.00531	CbGeAlD
Gefitinib—CYP2D6—liver—gallbladder cancer	0.000192	0.00522	CbGeAlD
Gefitinib—ABCB1—liver—gallbladder cancer	0.000138	0.00376	CbGeAlD
Gefitinib—ABCB1—lymph node—gallbladder cancer	0.000106	0.00288	CbGeAlD
Gefitinib—ERBB3—B Cell Activation—HRAS—gallbladder cancer	6.64e-05	0.000766	CbGpPWpGaD
Gefitinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	6.6e-05	0.00076	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—NRAS—gallbladder cancer	6.55e-05	0.000755	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—ERBB4—gallbladder cancer	6.52e-05	0.000752	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—BCL2—gallbladder cancer	6.47e-05	0.000746	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB2—gallbladder cancer	6.36e-05	0.000733	CbGpPWpGaD
Gefitinib—ERBB3—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	6.36e-05	0.000733	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—EGFR—gallbladder cancer	6.32e-05	0.000728	CbGpPWpGaD
Gefitinib—EGFR—Immune System—KEAP1—gallbladder cancer	6.31e-05	0.000727	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—ERBB2—gallbladder cancer	6.29e-05	0.000724	CbGpPWpGaD
Gefitinib—EGFR—Regulation of Actin Cytoskeleton—NRAS—gallbladder cancer	6.27e-05	0.000723	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—NRAS—gallbladder cancer	6.27e-05	0.000723	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	6.24e-05	0.000719	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—NRAS—gallbladder cancer	6.17e-05	0.000711	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—EGFR—gallbladder cancer	6.12e-05	0.000705	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—EGFR—gallbladder cancer	6.09e-05	0.000702	CbGpPWpGaD
Gefitinib—EGFR—ErbB1 downstream signaling—HRAS—gallbladder cancer	6.07e-05	0.000699	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—KRAS—gallbladder cancer	5.97e-05	0.000688	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—NRAS—gallbladder cancer	5.89e-05	0.000679	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—ERBB4—gallbladder cancer	5.87e-05	0.000677	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—NRAS—gallbladder cancer	5.86e-05	0.000676	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—ERBB3—gallbladder cancer	5.84e-05	0.000673	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—NRAS—gallbladder cancer	5.83e-05	0.000672	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—NRAS—gallbladder cancer	5.81e-05	0.000669	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—KRAS—gallbladder cancer	5.78e-05	0.000666	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—TP53—gallbladder cancer	5.78e-05	0.000666	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—KRAS—gallbladder cancer	5.75e-05	0.000663	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NRAS—gallbladder cancer	5.72e-05	0.00066	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—NRAS—gallbladder cancer	5.7e-05	0.000656	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	5.66e-05	0.000652	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—ERBB3—gallbladder cancer	5.64e-05	0.00065	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—KRAS—gallbladder cancer	5.64e-05	0.00065	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—NRAS—gallbladder cancer	5.56e-05	0.000641	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—NRAS—gallbladder cancer	5.46e-05	0.00063	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—NRAS—gallbladder cancer	5.46e-05	0.00063	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	5.46e-05	0.00063	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—NRAS—gallbladder cancer	5.41e-05	0.000624	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	5.4e-05	0.000622	CbGpPWpGaD
Gefitinib—EGFR—Regulation of Actin Cytoskeleton—KRAS—gallbladder cancer	5.4e-05	0.000622	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—ERBB4—gallbladder cancer	5.38e-05	0.000621	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	5.37e-05	0.000618	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—NRAS—gallbladder cancer	5.34e-05	0.000616	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	5.34e-05	0.000615	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—KRAS—gallbladder cancer	5.31e-05	0.000612	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—TP53—gallbladder cancer	5.3e-05	0.000611	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—BCL2—gallbladder cancer	5.16e-05	0.000594	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—ERBB4—gallbladder cancer	5.15e-05	0.000593	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—ERBB3—gallbladder cancer	5.08e-05	0.000585	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—HRAS—gallbladder cancer	5.07e-05	0.000585	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—KRAS—gallbladder cancer	5.07e-05	0.000585	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—EGFR—gallbladder cancer	5.07e-05	0.000584	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—NRAS—gallbladder cancer	5.06e-05	0.000583	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—KRAS—gallbladder cancer	5.05e-05	0.000582	CbGpPWpGaD
Gefitinib—EGFR—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	5.05e-05	0.000582	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—TP53—gallbladder cancer	5.04e-05	0.000581	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—KRAS—gallbladder cancer	5.02e-05	0.000579	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—ERBB2—gallbladder cancer	5.01e-05	0.000578	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—KRAS—gallbladder cancer	5e-05	0.000576	CbGpPWpGaD
Gefitinib—ERBB3—Disease—ERBB4—gallbladder cancer	4.97e-05	0.000573	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—ERBB4—gallbladder cancer	4.94e-05	0.00057	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	4.93e-05	0.000568	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—HRAS—gallbladder cancer	4.91e-05	0.000566	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—KRAS—gallbladder cancer	4.9e-05	0.000565	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—ERBB2—gallbladder cancer	4.89e-05	0.000564	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—HRAS—gallbladder cancer	4.89e-05	0.000564	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	4.87e-05	0.000561	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	4.84e-05	0.000558	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—ERBB2—gallbladder cancer	4.81e-05	0.000555	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—HRAS—gallbladder cancer	4.79e-05	0.000552	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—KRAS—gallbladder cancer	4.79e-05	0.000552	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—NRAS—gallbladder cancer	4.78e-05	0.000551	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	4.74e-05	0.000547	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—KRAS—gallbladder cancer	4.7e-05	0.000542	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	4.7e-05	0.000542	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—KRAS—gallbladder cancer	4.7e-05	0.000542	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—TP53—gallbladder cancer	4.68e-05	0.00054	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	4.68e-05	0.000539	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—KRAS—gallbladder cancer	4.66e-05	0.000537	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	4.62e-05	0.000532	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—KRAS—gallbladder cancer	4.6e-05	0.00053	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	4.59e-05	0.000529	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—ERBB4—gallbladder cancer	4.57e-05	0.000527	CbGpPWpGaD
Gefitinib—MKNK1—Disease—ERBB2—gallbladder cancer	4.55e-05	0.000524	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—HRAS—gallbladder cancer	4.51e-05	0.00052	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—ERBB4—gallbladder cancer	4.48e-05	0.000517	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—ERBB3—gallbladder cancer	4.45e-05	0.000513	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—ERBB2—gallbladder cancer	4.43e-05	0.00051	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	4.42e-05	0.00051	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TP53—gallbladder cancer	4.36e-05	0.000502	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—EGFR—gallbladder cancer	4.36e-05	0.000502	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—KRAS—gallbladder cancer	4.35e-05	0.000501	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—HRAS—gallbladder cancer	4.31e-05	0.000497	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—BCL2—gallbladder cancer	4.29e-05	0.000495	CbGpPWpGaD
Gefitinib—EGFR—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	4.29e-05	0.000494	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—HRAS—gallbladder cancer	4.29e-05	0.000494	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—ERBB3—gallbladder cancer	4.27e-05	0.000492	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—HRAS—gallbladder cancer	4.27e-05	0.000492	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—HRAS—gallbladder cancer	4.25e-05	0.00049	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	4.19e-05	0.000483	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—ERBB2—gallbladder cancer	4.17e-05	0.000481	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	4.16e-05	0.00048	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	4.14e-05	0.000477	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—KRAS—gallbladder cancer	4.12e-05	0.000474	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—HRAS—gallbladder cancer	4.07e-05	0.000469	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	4.02e-05	0.000464	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle—TP53—gallbladder cancer	4.01e-05	0.000462	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—HRAS—gallbladder cancer	4e-05	0.000461	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—HRAS—gallbladder cancer	4e-05	0.000461	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	4e-05	0.000461	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—HRAS—gallbladder cancer	3.96e-05	0.000456	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—ERBB3—gallbladder cancer	3.95e-05	0.000455	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	3.93e-05	0.000453	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	3.93e-05	0.000452	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—HRAS—gallbladder cancer	3.91e-05	0.00045	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—ERBB3—gallbladder cancer	3.88e-05	0.000447	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—NRAS—gallbladder cancer	3.81e-05	0.000439	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—HRAS—gallbladder cancer	3.78e-05	0.000435	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—BCL2—gallbladder cancer	3.77e-05	0.000434	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—NRAS—gallbladder cancer	3.72e-05	0.000429	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—HRAS—gallbladder cancer	3.7e-05	0.000426	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—NRAS—gallbladder cancer	3.66e-05	0.000422	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—ERBB2—gallbladder cancer	3.66e-05	0.000422	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—ERBB4—gallbladder cancer	3.61e-05	0.000416	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	3.54e-05	0.000408	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—ERBB2—gallbladder cancer	3.54e-05	0.000408	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	3.51e-05	0.000405	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—HRAS—gallbladder cancer	3.5e-05	0.000403	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—ERBB4—gallbladder cancer	3.48e-05	0.000401	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—EGFR—gallbladder cancer	3.47e-05	0.0004	CbGpPWpGaD
Gefitinib—MKNK1—Disease—NRAS—gallbladder cancer	3.46e-05	0.000399	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	3.42e-05	0.000394	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	3.41e-05	0.000393	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—NRAS—gallbladder cancer	3.37e-05	0.000388	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—EGFR—gallbladder cancer	3.34e-05	0.000384	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—KRAS—gallbladder cancer	3.28e-05	0.000378	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—KRAS—gallbladder cancer	3.2e-05	0.000369	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—ERBB2—gallbladder cancer	3.18e-05	0.000367	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—NRAS—gallbladder cancer	3.17e-05	0.000366	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—ERBB2—gallbladder cancer	3.16e-05	0.000364	CbGpPWpGaD
Gefitinib—MKNK1—Disease—EGFR—gallbladder cancer	3.15e-05	0.000363	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—KRAS—gallbladder cancer	3.15e-05	0.000363	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—ERBB3—gallbladder cancer	3.12e-05	0.00036	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—BCL2—gallbladder cancer	3e-05	0.000346	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ERBB4—gallbladder cancer	3e-05	0.000345	CbGpPWpGaD
Gefitinib—MKNK1—Disease—KRAS—gallbladder cancer	2.98e-05	0.000343	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—ERBB2—gallbladder cancer	2.92e-05	0.000336	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—KRAS—gallbladder cancer	2.9e-05	0.000334	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ERBB4—gallbladder cancer	2.9e-05	0.000334	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—EGFR—gallbladder cancer	2.89e-05	0.000333	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—BCL2—gallbladder cancer	2.87e-05	0.000331	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—ERBB2—gallbladder cancer	2.79e-05	0.000322	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—HRAS—gallbladder cancer	2.79e-05	0.000321	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—NRAS—gallbladder cancer	2.79e-05	0.000321	CbGpPWpGaD
Gefitinib—EGFR—Disease—ERBB4—gallbladder cancer	2.77e-05	0.000319	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—KRAS—gallbladder cancer	2.73e-05	0.000315	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—HRAS—gallbladder cancer	2.72e-05	0.000314	CbGpPWpGaD
Gefitinib—ERBB3—Disease—ERBB2—gallbladder cancer	2.69e-05	0.000311	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—NRAS—gallbladder cancer	2.69e-05	0.00031	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—ERBB2—gallbladder cancer	2.68e-05	0.000309	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—HRAS—gallbladder cancer	2.68e-05	0.000309	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ERBB3—gallbladder cancer	2.59e-05	0.000299	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—EGFR—gallbladder cancer	2.54e-05	0.000292	CbGpPWpGaD
Gefitinib—MKNK1—Disease—HRAS—gallbladder cancer	2.53e-05	0.000292	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ERBB3—gallbladder cancer	2.51e-05	0.000289	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—BCL2—gallbladder cancer	2.5e-05	0.000288	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—ERBB2—gallbladder cancer	2.48e-05	0.000285	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—HRAS—gallbladder cancer	2.46e-05	0.000284	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—EGFR—gallbladder cancer	2.45e-05	0.000283	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—ERBB2—gallbladder cancer	2.43e-05	0.00028	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NRAS—gallbladder cancer	2.42e-05	0.000279	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—NRAS—gallbladder cancer	2.4e-05	0.000277	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—KRAS—gallbladder cancer	2.4e-05	0.000276	CbGpPWpGaD
Gefitinib—EGFR—Disease—ERBB3—gallbladder cancer	2.39e-05	0.000276	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	2.36e-05	0.000272	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—HRAS—gallbladder cancer	2.32e-05	0.000268	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—KRAS—gallbladder cancer	2.32e-05	0.000267	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	2.23e-05	0.000257	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—NRAS—gallbladder cancer	2.22e-05	0.000256	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—EGFR—gallbladder cancer	2.21e-05	0.000254	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—NRAS—gallbladder cancer	2.12e-05	0.000245	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—KRAS—gallbladder cancer	2.09e-05	0.00024	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—KRAS—gallbladder cancer	2.07e-05	0.000238	CbGpPWpGaD
Gefitinib—ERBB3—Disease—NRAS—gallbladder cancer	2.05e-05	0.000236	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—NRAS—gallbladder cancer	2.04e-05	0.000235	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—HRAS—gallbladder cancer	2.04e-05	0.000235	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—EGFR—gallbladder cancer	2.02e-05	0.000233	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	1.98e-05	0.000229	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—HRAS—gallbladder cancer	1.97e-05	0.000227	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—ERBB2—gallbladder cancer	1.96e-05	0.000226	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ERBB4—gallbladder cancer	1.94e-05	0.000223	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—KRAS—gallbladder cancer	1.91e-05	0.00022	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—ERBB2—gallbladder cancer	1.89e-05	0.000217	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NRAS—gallbladder cancer	1.88e-05	0.000217	CbGpPWpGaD
Gefitinib—ERBB3—Disease—EGFR—gallbladder cancer	1.87e-05	0.000215	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TP53—gallbladder cancer	1.85e-05	0.000214	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NRAS—gallbladder cancer	1.85e-05	0.000213	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—KRAS—gallbladder cancer	1.83e-05	0.000211	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HRAS—gallbladder cancer	1.77e-05	0.000204	CbGpPWpGaD
Gefitinib—ERBB3—Disease—KRAS—gallbladder cancer	1.76e-05	0.000203	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—HRAS—gallbladder cancer	1.76e-05	0.000203	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—KRAS—gallbladder cancer	1.75e-05	0.000202	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—EGFR—gallbladder cancer	1.72e-05	0.000198	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—EGFR—gallbladder cancer	1.68e-05	0.000194	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ERBB3—gallbladder cancer	1.68e-05	0.000193	CbGpPWpGaD
Gefitinib—EGFR—Immune System—BCL2—gallbladder cancer	1.67e-05	0.000193	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ERBB2—gallbladder cancer	1.62e-05	0.000187	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HRAS—gallbladder cancer	1.62e-05	0.000187	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—KRAS—gallbladder cancer	1.62e-05	0.000187	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—KRAS—gallbladder cancer	1.59e-05	0.000183	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ERBB2—gallbladder cancer	1.57e-05	0.000181	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—HRAS—gallbladder cancer	1.55e-05	0.000179	CbGpPWpGaD
Gefitinib—EGFR—Disease—ERBB2—gallbladder cancer	1.5e-05	0.000173	CbGpPWpGaD
Gefitinib—ERBB3—Disease—HRAS—gallbladder cancer	1.5e-05	0.000173	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—HRAS—gallbladder cancer	1.49e-05	0.000172	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NRAS—gallbladder cancer	1.49e-05	0.000172	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TP53—gallbladder cancer	1.44e-05	0.000166	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NRAS—gallbladder cancer	1.44e-05	0.000165	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HRAS—gallbladder cancer	1.38e-05	0.000159	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NRAS—gallbladder cancer	1.36e-05	0.000157	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—EGFR—gallbladder cancer	1.36e-05	0.000156	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—NRAS—gallbladder cancer	1.35e-05	0.000156	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HRAS—gallbladder cancer	1.35e-05	0.000156	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—EGFR—gallbladder cancer	1.31e-05	0.000151	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—KRAS—gallbladder cancer	1.28e-05	0.000148	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NRAS—gallbladder cancer	1.24e-05	0.000142	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—KRAS—gallbladder cancer	1.24e-05	0.000142	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NRAS—gallbladder cancer	1.2e-05	0.000138	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—KRAS—gallbladder cancer	1.17e-05	0.000135	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—KRAS—gallbladder cancer	1.16e-05	0.000134	CbGpPWpGaD
Gefitinib—EGFR—Disease—NRAS—gallbladder cancer	1.14e-05	0.000132	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TP53—gallbladder cancer	1.14e-05	0.000131	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TP53—gallbladder cancer	1.1e-05	0.000127	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HRAS—gallbladder cancer	1.09e-05	0.000126	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—EGFR—gallbladder cancer	1.09e-05	0.000126	CbGpPWpGaD
Gefitinib—EGFR—Immune System—KRAS—gallbladder cancer	1.06e-05	0.000123	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ERBB2—gallbladder cancer	1.05e-05	0.000121	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HRAS—gallbladder cancer	1.05e-05	0.000121	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TP53—gallbladder cancer	1.04e-05	0.00012	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—KRAS—gallbladder cancer	1.03e-05	0.000119	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—HRAS—gallbladder cancer	9.94e-06	0.000115	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HRAS—gallbladder cancer	9.9e-06	0.000114	CbGpPWpGaD
Gefitinib—EGFR—Disease—KRAS—gallbladder cancer	9.82e-06	0.000113	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TP53—gallbladder cancer	9.14e-06	0.000105	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HRAS—gallbladder cancer	9.04e-06	0.000104	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HRAS—gallbladder cancer	8.74e-06	0.000101	CbGpPWpGaD
Gefitinib—EGFR—Disease—HRAS—gallbladder cancer	8.35e-06	9.62e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NRAS—gallbladder cancer	7.99e-06	9.21e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—KRAS—gallbladder cancer	6.88e-06	7.93e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TP53—gallbladder cancer	6.11e-06	7.05e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HRAS—gallbladder cancer	5.85e-06	6.74e-05	CbGpPWpGaD
